Terns Pharmaceuticals, Inc.
TERN
$2.92
-$0.13-4.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.71% | 26.28% | -27.05% | -3.93% | -32.85% |
| Total Depreciation and Amortization | -2.73% | -7.21% | 10.60% | 6.31% | -5.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.33% | -66.13% | 18.21% | 17.00% | -33.55% |
| Change in Net Operating Assets | 3,342.24% | 131.14% | 73.93% | -216.04% | -108.46% |
| Cash from Operations | 24.50% | 20.50% | -24.52% | -58.52% | -72.30% |
| Capital Expenditure | 100.00% | 100.00% | -- | -- | -29.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -299.57% | 242.34% | 146.46% | -71.26% | 425.77% |
| Cash from Investing | -299.75% | 242.29% | 146.45% | -71.37% | 424.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.55% | 816,735.00% | -18.40% | -- | -86.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -97.81% | 816,360.00% | -18.40% | -- | -86.92% |
| Foreign Exchange rate Adjustments | -127.06% | 255.88% | 85.11% | -160.00% | 466.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -358.60% | 515.19% | 125.52% | -136.06% | -47.63% |